- life sciences/pharma sector
-
3rd Annual Advanced Pharma Resource Planning & Portfolio Management
New Innovations in Resource Allocation and Portfolio Management in a Changing Pharmaceutical Environment
Event Date: 24-26 Feb 2010
Location: Hilton City Avenue, Philadelphia, PA, USA
- key conference speakers
-
Alan M. Krensky, MD Senior Investigator, National Cancer Institute. Former Director of the Office of Portfolio Analysis and Strategic Initiatives, National Institutes of Health Steve Eby Vice President, Biomedical Forecast & Planning, Genzyme Su Narayanan, PhD Vice President of Project Management and Strategic Planning, Oncology and Internal Medicine, Sanofi-Aventis Steven Bjornson Strategic Planning Director, Pfizer BioTherapeutics R&D, Pfizer
- key conference topics
-
- Pre-Conference workshop presented by GenSight -
- Strategize resource allocation and project management initiatives to better prepare for the changing pharmaceutical industry
- Improve portfolio valuation and product management practices to better predict pipeline risks, forecast variables and increase ROI amidst portfolio consolidation and optimization practices
- Move from a project-based model to a radically innovative Center-of-Excellence model when structuring R&D and clinical trials
- Address M&A concerns and develop critical game plans for efficient portfolio management & capacity allocation transition
- conference focus
-
By attending this conference, attendees will learn best practices in strategic portfolio planning and selection, optimization By attending this conference, attendees will learn best practices in strategic portfolio planning and selection, optimization of capacity planning, and optimal resource allocation. Attendees will gain valuable industry leaders’ perspectives who have successfully implemented and improved on the accuracy of portfolio management, project management and resource demand forecasts. The traditional challenges faced by project management, portfolio maximization and risk management is ever present even without a changing landscape. This conference addresses the ongoing concerns for portfolio management, project management and resource allocation. Additionally it addresses the challenges faced within these critical functions in a changing environment, including globalization, changing regulatory constraints, outsourcing, mergers and acquisitions and other challenging environments faced by Pharma and Biotech companies today.